Immobilization by 21 days of bed rest results in type II collagen degradation in healthy individuals.


OBJECTIVE: To investigate the effects of 21 days of bed rest immobilization (with and without exercise and nutrition interventions) on type II collagen biomarker concentrations in healthy individuals. DESIGN: Twelve healthy male participants (age 34.2 +/- 8.3 years; body mass index 22.4 +/- 1.7 kg/m(2)) were exposed to 6 days ambulatory baseline data collection (BDC), 21 days head-down-tilt bed rest (HDT, CON) + interventions (HDT + resistive vibration exercise (2 times/week, 25 minutes): RVE; HDT + RVE + whey protein (0.6 g/kg body weight/day) and bicarbonate supplementation (90 mmol KHCO(3)/day: NeX), and 6 days of re-ambulation (R) in a cross-over designed study. The starting HDT condition was randomized (CON-RVE-NEX, RVE-NEX-CON, NEX-CON-RVE). Blood and urine samples were collected before, during, and after HDT. Serum concentrations (s) of CPII, C2C, C1,2C, and urinary concentrations (u) of CTX-II and Coll2-1NO2 were measured. RESULTS: Twenty-one days of HDT resulted in increased sCPII (p < 0.001), sC2C (p < 0.001), and sC1,2C (p = 0.001) (highest increases: sCPII (+24.2% - HDT5), sC2C (+24.4% - HDT7), sC1,2C (+13.5% - HDT2). sC2C remained elevated at R+1 (p = 0.002) and R+6 (p < 0.001) compared to baseline. NeX led to lower sCPII (p < 0.001) and sC1,2C (p = 0.003) compared to CON. uCTX-II (second void and 24-hour urine) increased during HDT (p < 0.001, highest increase on HDT21: second void +82.8% (p < 0.001); 24-hour urine + 77.8% (p < 0.001). NeX resulted in lower uCTX-II concentrations in 24-hour urine (p = 0.012) compared to CON. CONCLUSIONS: Twenty-one days of bed rest immobilization results in type II collagen degradation that does not recover within 6 days of resuming ambulation. The combination of resistive vibration exercise and protein/bicarbonate supplementation minimally counteracted this effect.

Author: Liphardt AM, Godonou ET, Dreiner M, Mundermann A, Tascilar K, Djalal N, Heer M, Schett G, Zaucke F, Niehoff A

Organization: Department of Internal Medicine 3 - Rheumatology Deutsches Zentrum Immuntherapie (DZI), Universitatsklinikum Erlangen

Year: 2024

GID: 6146

Created on: 19.02.2024

The verdict of our customers: Excellent


4.7 out of 5 stars based on 868 reviews

TÜV certified

We are a TÜV certified manufacturer for medical products.

Made in Germany

Development and manufacturing in Germany.

Proven quality

10 years service guarantee & more than 35 years experience in the company group.

Research studies

over 2000 scientific publications about our products.

Active worldwide

Internationally active with our distribution partners.

Start typing to see posts you are looking for.